Article Figures & Data
Figures
- Figure 1.
PFS in Intention to Treat Population
Reproduced from Rosell R et al. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncology 2012;13(3):239–246. With permission from Elsevier.
- Figure 2.
Effects of Imatinib Withdrawal in GIST Patients
Reproduced from Le Cesne A et al. Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial. Lancet Oncology 2010;11(10):942–949. With permission from Elsevier.
Tools
Table of contents
Cited By...
- No citing articles found.